Method for preventing or treating skin tumor
AssigneeGalderma Research & Development
InventorsGuy Bouvier, Matthew James Leoni, Michael Graeber
Life of this patent
Estimating the term…
Abstract
Methods, compositions and products for preventing skin tumor formation or inhibiting development of an existing skin tumor in a subject are described. The methods involve administering to the subject a composition containing an α2 adrenergic receptor agonist, such brimonidine.
Claims12
A method of inducing cell death and inhibiting the progression of an existing skin tumor in a subject in need thereof, comprising administering to the subject a composition comprising a therapeutically effective amount of an α2 adrenergic receptor agonist and a pharmaceutically acceptable carrier.
A method of inducing cell death and inhibiting the growth of a skin tumor cell in a subject, comprising topically administering to the subject a composition comprising an α2 adrenergic receptor agonist in an amount sufficient to induce the death or inhibit the growth of the skin tumor cell.
A method of inducing cell death and inhibiting the progression of an existing skin tumor in a subject in need thereof, comprising administering to the subject a composition comprising a therapeutically effective amount of brimonidine and a pharmaceutically acceptable carrier.
A method of inducing cell death and inhibiting the growth of a skin tumor cell in a subject, comprising topically administering to the subject a composition comprising brimonidine in an amount sufficient to induce the death or inhibit the growth of the skin tumor cell.
Dependencies are inferred from the claim text.